Sidley is one of the few law firms that can boast a top-tier life sciences transactions practice on-the-ground in China. Life sciences companies and investors in China and Asia rely on us for their collaboration and licensing matters because we offer a formidable combination of deep life sciences transactional experience and unparalleled sector knowledge.
- As part of the firm’s Global Life Sciences group, our team in China collaborates across disciplines with lawyers in the U.S. and Europe to offer a holistic legal approach to partnering and commercial transactions.
- Insightful experience in a virtually full array of issues throughout licensing transactions.
- Helping clients identify and address their key business needs in undertaking their transactions.
- Engaging in deals on the cutting-edge of scientific development, including AI and machine-learning, drug discovery, gene and cell therapy, and RNA therapies, among others.
Healthcare, Pharma, & Life Sciences Firm of the Year
China Business Law Journal 2014 and 2018–2024
